Secher, Anna

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 961

Semaglutide lowers body weight in rodents via distributed neural pathways.

Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 717

GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand

Yang, L., Chang, C.-C., Sun, Z., Madsen, D., Zhu, H., Padkjær, S. B., Wu, X., Huang, T., Hultman, K., Paulsen, S. J., et al. (2017) · Nature Medicine

GDF15 and Related BiomarkersRegulation of Appetite and Obesity

Cited by 668

A genetic map of the mouse dorsal vagal complex and its role in obesity

Ludwig, M. Q., Cheng, W., Gordian, D., Lee, J., Paulsen, S. J., Hansen, S. N., Egerod, K. L., Barkholt, P., Rhodes, C. J., Secher, A., et al. (2021) · Nature Metabolism

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 186

Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization

Jensen, C. B., Pyke, C., Rasch, M. G., Dahl, A. B., Knudsen, L. B., & Secher, A. (2018) · Endocrinology

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 145

Integrated brain atlas for unbiased mapping of nervous system effects following liraglutide treatment

Salinas, C. B. G., Lu, T. T.-H., Gabery, S., Marstal, K., Alanentalo, T., Mercer, A. J., Cornea, A., Conradsen, K., Hecksher-Sørensen, J., Dahl, A. B., et al. (2018) · Scientific Reports

Cell Image Analysis TechniquesNeuroscience and Neuropharmacology Research

Cited by 95

Proteomic changes upon treatment with semaglutide in individuals with obesity

Maretty, L., Gill, D., Simonsen, L., Soh, K., Zagkos, L., Galanakis, M., Sibbesen, J., Iglesias, M. T., Secher, A., Valkenborg, D., et al. (2025) · Nature Medicine

Pharmacology and Obesity TreatmentAdipokines, Inflammation, and Metabolic Diseases

Cited by 86

CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure

Jacobsen, J. M., Halling, J. F., Blom, I., Moreno Martinez, J., Hald, B., Pedersen, K., Fels, J. J., Snitker, S., Secher, A., Lundh, S., et al. (2025) · Nature Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 15